IP Library Granted Patent US 8,062,490
Granted Patent B2
US 8,062,490 · App. 12/724,280 · Granted Nov 22, 2011

Reagent compositions for use in electrochemical detection

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,062,490
App. No.
12/724,280
Granted
Nov 22, 2011
Kind
B2
Abstract

Biological reagent compositions with improved sensitivity to the concentration of blood glucose in patient samples for use in measuring systems and methods. The reagent compositions comprise a glucose oxidoreductase enzyme, a flavin nucleoside coenzyme and a mediator formulation. The mediator formulation comprises at least one electroactive organic molecule and at least one coordination complex.

Claims (34)

1. A reagent for detecting an analyte, comprising:

a glucose oxidoreductase;

a coenzyme selected from a flavin nucleoside and a nicotinamide nucleotide; and

a mediator formulation comprising at least one electroactive organic molecule independently selected from a phenoxazine or a phenoxazinium salt, and at least one coordination complex selected from osmium and ruthenium complexes.

2. The reagent according to claim 1 , wherein the coenzyme is flavin adenine dinucleotide.

3. The reagent according to claim 1 , wherein the glucose oxidoreductase is glucose dehydrogenase.

4. The reagent according to claim 1 , wherein the at least one electroactive organic molecule is independently selected from a benzophenoxazine or a benzophenoxazinium salt.

5. The reagent according to claim 1 , wherein the at least one coordination complex is a ruthenium complex.

6. The reagent according to claim 1 , wherein the coenzyme is nicotinamide adenine dinucleotide.

7. A reagent for detecting an analyte, comprising:

a glucose oxidoreductase;

a coenzyme selected from a flavin nucleoside and a nicotinamide nucleotide; and

a mediator formulation comprising at least one electroactive organic molecule independently selected from a benzophenoxazine or a benzophenoxazinium salt, and at least one coordination complex independently selected from osmium and ruthenium complexes.

8. The reagent according to claim 7 , wherein the glucose oxidoreductase is a glucose dehydrogenase.

9. The reagent according to claim 7 , wherein the coenzyme is flavin adenine dinucleotide.

10. The reagent according to claim 7 , wherein the coordination complex is a ruthenium complex.

11. The reagent according to claim 7 , wherein the at least one electroactive organic molecule is independently selected from 9-(dimethylamino)benzophenoxazin-7-ium chloride, N-(9H-benzophenoxazin-9-ylidene)-N-methylmethanaminium chloride, or 8-dimethylamino-2,3-benzophenoxazine.

12. The reagent according to claim 7 , wherein the coenzyme is nicotinamide adenine dinucleotide.

13. A reagent for detecting an analyte, comprising:

a glucose oxidoreductase;

a coenzyme selected from a flavin nucleoside and a nicotinamide nucleotide; and

a mediator formulation comprising at least one electroactive organic molecule independently selected from a benzophenoxazine or a benzophenoxazinium salt, and at least one ruthenium coordination complex.

14. The reagent according to claim 13 , wherein the glucose oxidoreductase is a glucose dehydrogenase.

15. The reagent according to claim 13 , wherein the flavin nucleoside coenzyme is flavin adenine dinucleotide.

16. The reagent according to claim 13 , wherein the coordination complex is ruthenium hexamine.

17. The reagent according to claim 13 , wherein the at least one electroactive organic molecule is independently selected from 9-(dimethylamino)benzophenoxazin-7-ium chloride, N-(9H-benzophenoxazin-9-ylidene)-N-methylmethanaminium chloride, 8-dimelthylamino-2,3-benzophenoxazine hemi (zinc chloride) salt, 7-dimethylamino-1,2-benzophenoxazine or 8-dimethylamino-2,3-benzophenoxazine.

18. The reagent according to claim 13 , wherein the coenzyme is nicotinamide adenine dinucleotide.

19. A reagent for detecting an analyte, comprising:

glucose dehydrogenase;

a coenzyme selected from flavin adenine dinucleotide and nicotinamide adenine dinucleotide; and

a mediator formulation comprising at least one electroactive organic molecule independently selected from a benzophenoxazine or a benzophenoxazinium salt, and at least one ruthenium complex.

20. The reagent according to claim 19 , wherein the at least one electroactive organic molecule is independently selected from 9-(dimethylamino)benzophenoxazin-7-ium chloride, N-(9H-benzophenoxazin-9-ylidene)-N-methylmethanaminium chloride, 8-dimelthylamino-2,3-benzophenoxazine hemi (zinc chloride) salt, 7-dimethylamino-1,2-benzophenoxazine or 8-dimethylamino-2,3-benzophenoxazine.

21. The reagent according to claim 19 , wherein the at least one ruthenium complex is ruthenium hexamine.

22. The reagent according to claim 20 , wherein the at least one ruthenium complex is ruthenium hexamine.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Aug 29, 2025
From: WELLS FARGO BANK, NATIONAL ASSOCIATION
To: TRIVIDIA HEALTH, INC.
Reel/Frame 072743/0697 →
CHANGE OF NAME Recorded Mar 4, 2016
From: NIPRO DIAGNOSTICS, INC.
To: TRIVIDIA HEALTH, INC.
Reel/Frame 038002/0867 →
SECURITY AGREEMENT Recorded Nov 5, 2013
From: NIPRO DIAGNOSTICS, INC.
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 031580/0094 →
RELEASE OF SECURITY INTEREST Recorded Nov 5, 2013
From: REGIONS BANK
To: NIPRO DIAGNOSTICS, INC.
Reel/Frame 031581/0955 →
SECURITY AGREEMENT Recorded Aug 24, 2012
From: NIPRO DIAGNOSTICS, INC.
To: REGIONS BANK
Reel/Frame 028840/0948 →
CHANGE OF NAME Recorded Jul 14, 2010
From: HOME DIAGNOSTICS, INC.
To: NIPRO DIAGNOSTICS, INC.
Reel/Frame 024678/0455 →